MCERLANE DAVID (Group President, Biologics) received a stock award from CATALENT, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/18/2024ACC: 0000950170-24-137787
Officer· Group President, Biologics
Since Oct 2023
-51.04K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
11.43K acquired · 62.47K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−36.30K
Price / share
—
Trade value
—
% of position
New position
12/18/2024
36.30K→0.00
Common Stock
Direct
Shares
+11.43K
Price / share
—
Trade value
—
% of position
New position
12/18/2024
0.00→11.43K
Common Stock
Direct
Shares
−11.43K
Price / share
—
Trade value
—
% of position
New position
12/18/2024
11.43K→0.00
Total
Net shares
−36.30K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/18/2024 | D · Disposition | −36.30K | — | — | New position | 36.30K | 0.00 |
| Common Stock Direct | 12/18/2024 | A · Award | +11.43K | — | — | New position | 0.00 | 11.43K |
| Common Stock Direct | 12/18/2024 | D · Disposition | −11.43K | — | — | New position | 11.43K | 0.00 |
| Total | −36.30K | $0.00 | ||||||
Derivative Transactions1
Option to purchase Common Stock
Direct
Converts to
Common Stock
14.74K shares
Shares
−14.74K
Strike price
45.79
Held after
0.00
Exercisable
—
12/18/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to purchase Common Stock Direct | Common Stock14.74K shares | 12/18/2024 | D · Disposition | −14.74K | 45.79 | — | 0.00 |